Compte-rendu du congrès de l'ISPOR 2017: Big data en santé selon l'ISPOR: Quelles réalités en 2017 et pour quelles perspectives ?

The 22nd ISPOR (International society for pharmacoeconomics and outcomes research) Conference was held in Boston, May 20-24, 2017. A group of pharmacists, physicians and health economists attended the conference and reported some of the highlights. During the congress, there was a widespread and enthusiastic debate on the exploitation of big data, their usefulness for health policy decisions and coming challenges. In this paper, the authors discussed the following questions from the different sessions and/or posters: Real-life databases: What are they? What reliability and methodologies? What operating potentials? What uses are applied to medical devices? Will they be able to supplement the randomized clinical trials?.